Cloud Computing for Pharma: The Road to Digital Transformation Posted on September 18, 2024November 14, 2024 by Marta Fetsatchyn Massive challenges like the global pandemic forced many industries to rethink how they handle data storage, and pharma was no exception. When COVID hit, the urgent need to accelerate drug development meant shrinking timelines from years to months, with no room for compromises on quality. Cloud computing was one of the facilitators of this shift. Cloud-based tools allowed pharma companies to capture and share clinical data between research teams both securely and quickly. The rest is history: vaccines were delivered worldwide in record time, saving millions of lives. In this article, we will explore the main use cases for cloud computing in pharmaceutical industry, its benefits, and the challenges that still need to be addressed. Intro to Cloud Computing in Pharma Cloud computing gives life sciences companies a flexible way to handle data storage. Instead of pouring money into physical data centers and servers, they can access remote, on-demand, storages as needed. This allows them to scale quickly, gain a competitive edge, and save money for more important things like research and development. Let’s not forget the massive amount of data the life sciences industry generates daily. Cloud-based systems help eliminate data silos, allowing companies to better use their data to drive business growth. Cloud computing empowers life sciences organizations to transform various business processes and adopt innovative technologies like artificial intelligence (AI). Why Cloud Computing is Crucial in the Pharmaceutical Industry Cloud technologies have revolutionized the life sciences industry. Let’s explore the areas that have seen the most significant changes. Cloud computing accelerates drug discovery The gap between companies investing in cloud technologies and those avoiding it is set to grow. For example, AstraZeneca, which relies on cloud solutions to accelerate drug research and development, will likely get products to market faster than any company that has resisted this digital transformation. “Ultimately, the cloud is the latest example of Schumpeterian creative destruction: creating wealth for those who exploit it; and leading to the demise of those that don’t.” – Joe Weinman, Senior VP at Telx. This innovative approach has brought more than 40 successful drug discovery projects to AstraZeneca. Thanks to its partnership with AWS, it can conduct 51 billion statistical tests in less than 24 hours. By the end of 2026, the company will be able to analyze two million genomes. Isn’t scalability one of the most important goals each drug manufacturer is striving for? Thanks to cloud computing, research teams can collaborate and share their findings securely and efficiently. This allows scientists to analyze lab results and draw conclusions more quickly. Life sciences companies can adopt third-party software-as-a-service (SaaS) solutions for drug discovery or build custom tools in collaboration with a cloud provider. For instance, many pharmaceutical companies use cloud-based platforms for remote research and development labs, regulatory compliance, and clinical trial data management. Cloud computing facilitates effortless collaboration Cloud computing makes it easier for life sciences companies to communicate and collaborate globally. With cloud platforms, professionals can share ideas, seek second opinions, and fill knowledge gaps faster, speeding up breakthroughs in healthcare. Today, cloud-based collaboration tools help stakeholders keep communication open at every product lifecycle stage, from discovery to manufacturing. Cloud applications also let healthcare providers (HCPs) cooperate with patients, track their side effects, and prompt patients to seek care when needed. For example, the Centers for Disease Control and Prevention (CDC) teamed up with Oracle to develop a cloud-based health check system that allowed the reporting of COVID-19 vaccine side effects. This quick reporting helped the CDC gather crucial data on the vaccine’s effectiveness, contributing to its further improvements. Medical journals then used this data to debunk myths about the vaccine circulating online and raise public awareness about the deadly virus. Cloud computing provides secure data sharing for clinical trials High dropout rates in longitudinal trials are a big concern for drug manufacturers. An analysis of 71 randomized controlled trials published in leading medical journals shows that 18% of trials have a dropout rate of 20%, which leaves room for biased clinical results. Why do so many patients leave the clinical trials? Many are still designed with life sciences companies in mind, requiring patients to make frequent hospital visits without compensation for their time or effort. Cloud computing is helping to change this by enabling decentralized clinical trials. Source: Pharma Technology Focus Cloud solutions have shifted the burden away from patients. With decentralized trials, patients can now report their health status from the comfort of their homes. With less time commitment and fewer scheduling conflicts, it is no surprise that dropout rates have decreased dramatically. Besides, cloud computing pairs well with AI, allowing scientists to analyze clinical trial data with surgical precision. This is especially helpful in recruiting participants and designing the trials. The cloud also merges with other technologies like electronic health records (EHRs), wearables, telemedicine, and mobile apps, enhancing patient engagement and communication. Sano Genetics is a great example of a cloud app that connects patients with clinical research opportunities tailored to their genetic data. Its Virtual Waiting Room provides personalized content to keep users engaged between trial stages, which helps boost compliance rates. Cloud computing helps to comply with regulations Cloud technology helps life sciences companies navigate a heavily regulated industry without the need to gather physical dossiers. The regulatory submission process has become much smoother and quicker. The regulatory bodies can now access company data directly from cloud servers and track drug safety in real-time. Traditional pharmacovigilance leads to time-consuming manual reporting. Cloud computing makes real-time monitoring possible, allowing timely detection of drug safety signals. The data submitted to the cloud lets regulators perform instant analysis and expedite approvals. What’s more, pharmaceutical regulations change and evolve rapidly, making compliance quite tricky. Cloud technology empowers companies to trace regulatory changes and revise processes and procedures accordingly. Cloud computing improves supply chain resilience Counterfeit products are a serious issue in the life sciences industry, posing a significant threat to patient health and safety. Cloud computing enhances transparency in the supply chain by enabling drug manufacturers to trace every component back to its origin. Real-time monitoring of a drug’s location drastically reduces the possibility of errors and prevents counterfeiting. Cloud-based systems collect data at every stage of the drug’s journey, combating the grey market and ensuring product authenticity. Cloud computing enhances pharmaceutical marketing efforts It is no secret that great marketing starts with having complete, high-quality data. Traditional on-premises systems often struggle with data silos, making it hard to share information and perform solid data analysis. This stifles effective customer segmentation, personalization, and omnichannel marketing efforts. Cloud computing solves this by allowing brands to centralize terabytes and petabytes of data securely. Marketing teams can easily collaborate with other departments and clients, sharing documents and files to create compelling campaigns. Additionally, advanced cloud analytics provide key insights into how to guide HCPs and patients through the sales funnel. It gives marketers a clear view of what really matters to customers – and what is holding them back. Let’s say an HCP browses a pharmaceutical company’s website. Cloud data analytics can monitor the pages they explore, the links they click, and even the areas where they linger. Marketers can then leverage this data to tailor personalized content that meets their specific needs. Not to mention, this kind of personalization is possible in real-time. Cloud technology coupled with AI data analytics helps life sciences companies gain data-driven insights and create engaging, relevant content on the fly. Example of real-time content personalization By analyzing the HCP’s actions on the website, AI-driven cloud analytics can choose the most relevant pre-approved modules and create content that is tailored to their immediate needs. Since customer preferences can shift rapidly, this gives pharmaceutical brands a significant competitive edge in engaging their audience. Let’s Talk Numbers The cloud market is piping hot right now. According to recent statistics, 95% of companies in sectors like public services, manufacturing, IT and technology, retail, and finance now use cloud solutions. It is no surprise that the global market is growing at a compound annual rate of 20%. Another key finding: 96% of respondents said cloud-based systems have exceeded their expectations. However, the survey also shows that only 42% of companies have fully moved to the cloud, while 55% still rely on on-premises solutions to some extent. If the cloud is so effective, why are so many companies digging in their heels and resisting innovation? Let’s explore this further in the section below. Cloud Computing in Pharma Today: Challenges & Solutions Anything connected to the Internet can be vulnerable to cyberattacks. Moving your data from in-house servers to the cloud exposes your system to potential security risks. In addition, this change shifts responsibility for security from your organization to a third-party cloud provider, which can be difficult, especially if there are trust issues. However, if you choose a reliable cloud vendor like Amazon Web Services (AWS), Google Cloud, or Microsoft Azure, these extreme worries are often overblown. Leading providers typically have hundreds of experts dedicated to data security, ensuring your data remains safe and is not accessed by unauthorized third parties. Data sovereignty is another key concern for most pharmaceutical brands as they decide whether to move to the cloud. Personal data is subject to the legal regulations of the country where the individual resides, which can make cloud adoption painful. For instance, if you are based in Greece and want to work with a trusted provider like AWS, you could run into data sovereignty issues, as AWS does not have a data center in your country. To address this, many major cloud providers set up data centers in various countries to enable local data storage. Yet, they must navigate different internet governance regulations to make this happen. Moving to the Cloud with Ease These days, nearly every sector has its own success story of moving to the cloud. However, this shift did not happen overnight. It has brought significant changes to companies of all sizes, impacting everything from business operations to internal processes. If you want to change your infrastructure, the Viseven team is here to guide you through the entire journey. We have over a decade of expertise delivering our cloud-based content experience platform, eWizard, and helping numerous pharmaceutical companies make a smooth move to the cloud. Our cloud services also cover cloud architecture design, consulting, management, DevOps as a service, and cloud cost optimization. Ready to turn the page to the cloud-based future? Get in touch, and we will reach out to you soon.
How to Engage with Amazon’s Omnichannel Strategy in Pharma Industry? Posted on January 28, 2020November 12, 2024 by Andrii Nikulin Omnichannel strategies are continuously implemented in many organizations that want to enhance their customers’ experience. Amazon’s omnichannel experiences are the keystone to customer retention that help to cover previous sales reductions. The omnichannel approach integrates offline and online channels where customers make purchase interactions via stores, websites, apps, mobile ads, push notifications, product pages, etc. Abstract View of Amazon’s Omnichannel Experience Amazon Omnichannel Retail provides a differentiated customer experience, so various channels smoothly correspond with each other to unchain an immersive journey for the customer demands and purchasing capacities. Instead of running in parallel, the communication channels and the resources supporting them are designed and integrated to work together within the omnichannel solution. As a result, the experience of interacting across all of these channels becomes even more effective or enjoyable than using one channel separately. Why do you need to take advantage of this marketing approach? Let’s disclose it below. Amazon’s customer experience: excellence in service and satisfaction Amazon marketing strategy entails integration throughout various marketing channels such as social media, mobile app, push advertisements, newsletters, laptop purchasing, and chatbots that give easy access to products and services, improving the overall customer buying experience. For instance: Push notifications usually contain jokes or associated content. That attracts the attention and motivates customers to click through and go to the product web page where he sees descriptions of top-notch functions but hesitates to make purchase decisions. The system detects that the customer is long enough on the page; thus, the chatbot pops up with a live assistant to answer his questions and further works with the objections to complete sales. Such an omnichannel approach talks for itself. If you establish and set up such a level of excellence in your sales strategy with this approach, you will reach an increase in the KPI of your pharma business. Besides, pharma omnichannel marketing inspires customers to always prioritize your brand instead of shopping around. Research shows that: omnichannel leads to 90% higher customer retention than interaction through a single channel. That ultimately makes your products and services visible across multiple offline and online locations, highlighting the importance of purchasing and helping you earn more income for your pharmaceutical company. Omnichannel Amazon approach to Pharma customer engagement People have noted how smart and innovative Amazon is in its customer engagement strategies. What shapes them so unique? Most importantly, Amazon collects data on everyone from its audience while they use the shop on its site. Companies like Amazon are the pioneers of digital marketing. While Amazon didn’t invent omnichannel, it quickly embraced it and became a key component of its business model. Amazon knows every customer that buys from them and uses everyone’s data to provide a personalized and up-to-date experience. The central database is at the heart of their marketing model, which ensures seamless interaction between channel and device, which is the hallmark of omnichannel. Consumers flock to Amazon because they get a consistent and reliable experience that saves time and money and provides a high level of omnichannel customer service. They have a considerable arsenal of successful marketing tools to prove their point: SEO This is one of the most famous internet marketing techniques. SEO helps businesses appear as high as possible in search results for specific queries. Because so many product searchers start searching for purchases directly on Amazon’s web store (rather than Google), it has become the #1 product search engine on the internet. Keywords They are at the core of Amazon’s SEO tactics and make products more visible. Once all relevant keywords have been researched and assigned to a product, more search queries may show the relevant product in the search results for potential shoppers. Questions & Answers Amazon takes care of every question from its customers as they often ask for specific details that are not displayed on the product page. Answering questions can improve the information content of a product page, as questions often point to more significant information gaps. So, moderators can add new details to the product or service description focused on the client’s needs. These tools help Amazon collect data, effectively improve its service, and create a “360-degree view” of you as an individual customer. It is important to note that clients expect the same experience from the whole companies they cooperate with. How does it affect Pharma’s channel strategy? First, you get an excellent opportunity to interact with your target audience through the channel they prefer by developing a unified communication system with customers in which different channels complement each other. First, an omnichannel marketing strategy allows you to increase customer engagement and conversion as you can build a customer journey to get your audience to the information they need and are interested in. Thus you will get a higher response. Furthermore, with omnichannel marketing, you can reduce customer acquisition costs by developing a mix of channels to meet customer demand to win their loyalty. Of course, you will avoid wasteful spending. Finally, you can address the core challenge of any content-driven omnichannel strategy—delivering related content that customers will genuinely appreciate. With a constant stream of data across connected channels, you can track customer preferences and behavior in a new way—overcoming the limitations of some channels and seeing the bigger picture. There are things you can only see from a bird’s eye view of the entire customer experience journey, so omnichannel does just that. Modular Content: Pharma Digital Marketing Strategy by Viseven Most recently, we at Viseven introduced a new approach to content creation – Modular Content. Thanks to a thoughtful modular approach, you can use it everywhere once you create and approve it, from eDetailing to the website. We break the content into flexible, independent fragments making it easy to reuse, repurpose, and republish content without additional effort, cost, or resources. Now content creation becomes smart: either with the help of an agency or on your own according to requirements. That makes it possible to save time and budget for development while maintaining high-quality content. With the COPE approach, there is no unnecessary, redundant development. You can reuse and localize approved modules across all your omnichannel marketing channels. Check out the extended presentation: Engage like Amazon: omnichannel HCPs engagement for pharma marketing from Viseven. To find out more about the approach, fill out the form below to contact our team of experts.
How is Virtual Reality used in Healthcare and Pharma Industries? Posted on June 7, 2018November 25, 2024 by Andrii Nikulin The future is unpredictable on every occasion. It significantly influences our daily lives with more technologies that we couldn’t even imagine back in the day. From social networks and media to touchphones and complex applications, digitalization changed our way of perception of things. Even more, it has changed a lot of business approaches and industries. As for the pharma and life science industry, the digitalization and use of modern technologies became a like a breath of fresh air, forever impacting the most vital thing for healthcare in common — communication. Modern-day pharma faces the enormous challenge of shifting to more efficient ways of engaging doctors with the recent explosion of VR and AR technologies. What does it mean? Imagine presenting your clinical data simultaneously, using any suitable device instead of manually sorting out and laying huge rows of useless documentation on the table. The wide range of scientific resources and data usually contained from a bunch of digitals and charts can be presented in a visual form, hands-free, and portable whenever and wherever it is most in demand. “The pattern of activity in a brain region involved in spatial learning in the virtual world is completely different than when it processes activity in the real world,” said Mayank Mehta, a UCLA professor of physics, neurology, and neurobiology at UCLA College and the study’s senior author. Let’s see how virtual technology helps to build strong patient engagement. What is Virtual Reality in Medicine? Let’s start with what VR is. Usually, this is something associated with video gaming: users can watch some virtual objects superimposed on the display and sometimes even interact with them. Since 2012, technology production has become massive with a huge explosion of Oculus Rift, HTC Vive, Gear VR, and Google Cardboard. Since that, it has become a massive hit at medical conventions, conferences, and live events. Denise Strauss, former VP of cardiovascular marketing at Boehringer, now VP, and head of marketing at Sunovion Pharmaceuticals, notes: “For sales reps, rather than walking into a physician’s office with print material, the Google Cardboard VR experience immediately catches their attention.” At this point, virtual reality technology in healthcare can be easily confused with augmented reality (AR), as they share the idea of bringing virtual objects to the user’s perception. Yet VR and AR are significantly different. While VR devices are aimed to detach a person from real-life entirely, augmented content is a consequent response towards delivering information directly into users’ eyesight without losing touch with the real world. With AR, you stay in a physical world with added virtual elements. Hence, it might bring a better understanding of users’ real-world experiences. Still, we are going to focus more on virtual reality in healthcare. So what does it offer? 4 Production Modes are offered by Virtual Engagement: Theater mode 360-world video’s combination of content and images presented on a simulated theater screen can drive deeper engagement with your brand among its potential audience. For physicians, if it’s for training or educational purposes, VR solutions such as simulation can help get an inside view of patients’ inner processes and conditions, which are usually hidden. For example, how it feels to “experience” Parkinson’s disease or migraine, what symptoms may occur, or to view the whole migraine aura. 360-degree video The most widely used VR tool. Despite being unable to change the user’s position while watching, it remains a significant virtual immersive experience and education provider. With the help of VR equipment, patients may observe how the prescribed drugs and medicines work in 3D just before their eyes. Another example is LOROS hospice in Leicester, which created a VR film of a walk in a park to provide respite to terminally ill patients. Simulated 3D Environments Designing, implementing, and integrating 3D objects into the VR world with a particular software such as Cinema 4D or Maya allows users to determine their position. For example, the audience can interact with your drugs at the molecular level and integrate the data in a 3D world. Gesture-based Interactivity This activity has its peculiarity — the ability to recognize human gestures while interacting with VR objects. It works perfectly for patients with movement disorders. Implementation of Virtual Reality in Healthcare In modern healthcare, the use of VR is adopted to help patients and doctors achieve better results in treatments, including surgery, physical and cognitive rehabilitation, pain issues, mental health, and others. Medical Education and Training Modern medical universities like George Washington University are implementing VR into learning and medical training for real neurosurgery and thoracic surgery. VR allows for creating and exploring an operating room with a model of a patient’s brain and body before performing a procedure. It significantly improves the awareness of doctors doing surgery, patients lying under surgical blades, and even their families, who can better understand procedures ahead of time. Another good example is that the company that produces stents for cardiology or angioplasty can use VR to provide doctors with a safe experience. Instead of providing clinicians with reading materials and presentations, VR training creates an immersive space to describe a production process, explain usage, and educate about correct device implementation. Pain Management Did you know that your brain doesn’t differentiate between real and fake? We must look for additional triggers and questions to identify whether something is true. Meanwhile, our brain always lives “between worlds,” easily mixing the real world with imaginary stuff and not caring to discover what is what. Does it sound unpleasant to you? Either way, it works perfectly for such medical purposes as pain management. Thomas Caruso, MD, a pediatric anesthesiologist at Lucile Packard Children’s Hospital Stanford, states, “pain is a perception that’s coupled to your attention, mood, and emotions.” It means that if a patient’s mindset can be less focused on the surgery moment or other unpleasant nuances of medication, they will more likely feel less pain and struggle — significantly influencing the therapy. A good example is patients being busy with medical VR games and barely feeling the stick of a needle or an IV going in. Also, using VR helps patients to deal with the fear of dental care – or even losing it all — because of decreased pain. Physical Therapy and Rehabilitation At this point, using VR gives many healthcare possibilities. First, it allows clinicians or medicine developers to feel what the patient with Parkinson’s disease feels regarding movement. This experience will enable doctors to step into patients’ shoes and create a more accurate treatment approach based on practical knowledge. Second, it gives a proper rehabilitation space to help patients suffering from movement disorders and diseases. In the medical VR environment, the patient interacts with objects doing necessary exercises. The overall gamification of the procedure makes people forget about the pain and different psychological factors that may distract and interfere with rehabilitation. For example, children with complex regional pain syndrome (CRPS) experience pain in one or more limbs almost all the time. Medical VR games like squashing watermelons help them to focus more on the movements and the game rather than pain and stress. As a result, children’s confidence is increasing, and treatment improves. Virtual Reality in Pharmaceutical Sales Using VR tools gives enough space for unique promotion ideas for pharmaceutical companies. As marketing and sales communications are often a question of content and delivery, we all know upfront that PowerPoint presentations and PDF brochures with walls of text and strange infographics will bore healthcare professionals to death. As a result, you get the interruption of communication. Not quite an outcome you expect from your revenue teams, right? Your target audience will likely be impressed with what VR offers. This is where the “customer journey” term becomes literal: you can take the HCP through the prepared virtual project demonstrating the medication and how it works. Users can be presented with an analog of the human body and see how its health is affected by the medicine you present. VR in pharma marketing convinces people much stronger than any possible wording on your next sales slide. Pros and Cons of Virtual Reality in Healthcare VR technology isn’t for everyone. Unfortunately, it is not a cure-all for every disease, and its possibilities are limited. The implementation of VR may be costly and take some time. The VR hardware glasses range from 60$ (Google Daydream View) to $1,500 (HTC Vive Pro Eye Full Kit). Also, these kits are fragile and need to be maintained regularly. You may need additional software that fulfills your business needs. At this point, there’s a need to find an appropriate team of developers who can create a unique application for healthcare based on virtual engines like Unity or Unreal Engine. Some people may feel nausea, similar to motion sickness, as their vestibular apparatus did not adapt to the new environment. Getting used to VR may take some time or several sessions. The main problem is that VR is a young technology, and its use standards and policies are still being determined. It is getting less severe with every technology update — the better software and hardware, the fewer people feel the discomfort. Despite VR providing the best immersive experience, it is still not a panacea for education. A virtual environment works perfectly for describing information or engaging in new activities. However, it can not provide 100% immersion as it does not give a user proper hand control. For example, it can simulate surgery and let you go through every aspect of the operation. Still, it cannot give the feeling of a scalpel in hand, living tissue, and other nuances that are possible only in the real world. Nevertheless, the benefits of virtual reality in healthcare are much more significant and valuable to those whom it helps to stop struggling. As we listed above, from educational and training purposes to unique therapeutic experiences and rehabilitation, the future of virtual reality in healthcare is quite promising. See and feel for yourself: once you get your headset, there are thousands of medical applications of virtual reality which do not require a doctor’s prescription. Instead, these applications promise better health and wellness for specific conditions. For example, Embodied Labs, a company specializing in immersive educational technology, created an educational app for caretakers. This app holds several training sessions that address the issues of hearing loss, eyesight, and dementia. The healthcare market is growing, and the pharmaceutical sector will be constantly updated with new VR ideas and solutions, improving medical education and patients’ procedures of treatment. If you still have any questions about VR technology or want pharmaceuticalexpertise, do not hesitate to contact us. Our experts will provide you with full consultation.
Should Pharma Provide a Virtual Platform for HCP Engagement? Posted on February 1, 2017November 22, 2024 by Andrii Nikulin Are there any skills you once wanted to master online and dropped the idea because… whatever? Have you ever been watching too many How-to videos on YouTube, until you gradually lost interest? Or, perhaps, started a free-to-register course by a random author, only to find it discontinued – so you jumped over to a similar one and went through all the preliminaries, never to arrive at the really valuable stuff? Practice shows, a lot of people now seem trapped in the paralyzing amount of options when it comes to digital learning. When, earlier in the 2010s, there was a mighty explosion of countless online courses (MOOC), completion rates were as low as 10%. People are easily distracted these days, and still need guidelines as to where / in what order to get information. What does it have to do with pharma educating physicians? The answer is simple: continuity of learning experience that pharma needs to provide. A large, well-designed platform for providing HCPs with information is something many leading companies are working on right now, and it has its benefits. Maybe you heard the statistics on how long an average med rep visit lasts these days; you may be interested in providing informational value to your audience, which is the best way to cement reputation. However, the chief advantage of a virtual engagement platform is something even more significant, although not as obvious. It’s overcoming the fragmentation of customer experience in pharma marketing. After all, rep visits are not the only channel for doctors to get their information. More than 70% of healthcare practitioners look to the Internet when they need to know something. There are journals, research sites, branded pharma sites – and there is the towering figure of medical community they respect. A rep visit alone cannot provide consistent learning, it often feels unattached to the normal information flow – and that is the problem that virtual HCP engagement platforms can solve. Fractured Bits of Engagement Funnels (And How to Glue Them Together) The doctor was fidgeting with her phone, occasionally making eye contact with the rep. The visit had lasted for about four minutes now, but the lunch break was relentlessly coming to an end. Perhaps she would have to read that article on Crohn’s later in the day, after work. Meanwhile, the representative seemed overly enthusiastic about the brand new relief for IBS. – And did you know that over 34%… Brand new: the formula appeared nearly identical to the one described the day before. Only the brand was different. – It is surely interesting, – said the doctor, trying to sound patient. – I heard about it from your, erm… colleague from – – – . The rep was somewhat discouraged. – Very likely; however, I’d like to point out that unlike any other product offering a similar spectrum… Sigh. Now he is going to talk about guidelines and finally offer a link to the website. Open for all. Sigh. Good to know not all rep visits look like that – in fact, HCPs are actually interested in getting information from pharma, and there are many digital HCP engagement tools that can help companies. The doctor in the passage above is very much likely to go to the website when searching for that gastroenterology article. However, the truth is that in all of those episodes when doctors search for information they need, it comes in bits and scraps. The information that representatives provide is often repeated from one to another (62% of the time, doctors say) – and there’s no one to blame because given the duration of call, you are supposed to provide the required marketing “push” first. The valuable parts, where pharma’s good intentions of educating the audience lie buried, remain outside the time frame of the visit. This information is then absorbed online. It’s good when a rep’s visit is followed up; it’s bad that it’s followed up by just another brief episode. At the same time, pharmaceutical detailing is more educational by nature than any type of marketing imaginable. As we know, learning requires consistency. Not the bits and pieces of a marketing funnel. Especially not several completely different funnels from a number of brands. That’s why doctors sometimes prefer searching for information online over rep visits – and at the same time, they still want live talk with reps as part of their learning experience. If you try to represent this informational “ambient” graphically (as we did on the right), you will get a stable flow of guidelines/legal information, a big, turbulent but customizable stream of different content available online – and the scattered visits, occasionally provoking interest for websites, and sometimes followed up. Now, here’s the future of this ambient when the visits shrink in time as they do. Note that the value provided by one single visit is not even enough to incite further HCP engagement in pharma; the bit of information provided by reps are more easily lost when surrounded by competing companies’ bits and scraps – and the role of online learning increases to fill the space. Now, if you want to steer the general flow of interest, you will want to come up with something to glue together the scattered experiences – including the online ones (i.e., outside the doctor’s working hours). This “something” must be clearly related to the rep visits, but also provide more substantial information than can be given in 6 minutes or so. A virtual HCP platform is exactly the name given to this “something”. The idea is, this single major hub unites the different types of engagement and different formats of content in a single, customizable funnel. In this way, supposing the doctor is interested in some issue, they can either address the information online and then order an eDetailing session (possibly remote), or be “redirected” there by a rep. In both situations, the funnel doesn’t need to rely on a single type of engagement to continue – thanks to the broader definition of what follow-ups actually mean. This provides benefit for the HCPs, since they get their undisrupted learning experience, and is equally beneficial to the company, since audience retention suddenly becomes much, much easier. At the same time, the value of even the smallest bits of information (be it educational or marketing) rises drastically once they are part of a bigger education/promotion framework. This for That: Desirable Components Now, all of this may sound fabulous in general terms: a global platform to encompass all types of omnichannel HCP engagement, a place frequented by medical professionals, and all of them communicating freely with pharma… A skeptic would say it’s all a vague idea, a kind of umbrella notion. Wrap everything into one interface? What exactly is everything, after all? It would be unfair not to give any ideas as to what a good pharma HCP engagement platform can be made of. We found the most desirable building blocks for one based on the audience’s expectations, and they can be grouped in the way shown below. Of course, the main thing to bear in mind here is still integration. All the elements in a well-tailored platform should be perfectly accessible from one to another; navigation should suggest further content from anywhere. For example, it pays off to enhance textual or video content with an offer of an eDetailing session – so one should consider suggesting it automatically through a form. Everything should be connected, every element should lead to another one, so that the learning in not disrupted. Now, let’s look at the three major types of engagement in a platform. LIBRARIES Doctors get: resources Pharma gets: enhanced trust Who doesn’t want a convenient source of information? Searching the web for some particular content can be infuriating at times, so when a specialist sees that some resource spares them browsing time and has accumulated enough valuable content, they’ll stick to it. It is important to note that such projects work well when the amount of content is sufficient. This means a library is not made up only of product information and original research done by the company. It makes sense to fill the collection up with content curated from different sources, as well – in this way, the platform becomes more valuable to users because it serve as a hub. “Let me think… where should I go to find that stuff?” – so the library should cover enough for the audience. It’s not the corporate website – so general scientific information is more than welcome here. WEB CONFERENCES Doctors get: communication Pharma gets: data Medical community is a thing, and it was there long before pharmaceutical industry emerged. Regardless of whether or not pharma provides a place for doctors to exchange opinions, they will find the opportunity to do so. Why not create a communication environment that pharma is let in on? First of all, this is the perfect opportunity to make sure that web conferences held are attended by a thoroughly interested audience. It makes sense that, if you organize a meeting with KOLs and put effort into arranging for it, you’ll want your audience to be informed. What the platform does here is guarantee that the word gets spread. Secondly, data. By participating in professionals’ talks, pharma can get insights that escape the regular questionnaires and gain an insider view on the situation. REMOTE DETAILING Doctors get: convenience Pharma gets: increased frequency of calls / chance to steer engagement The discussion on whether rep visits are still relevant seems, by now, closed – and yes, almost everyone agrees we need reps. What makes detailing unsatisfactory is not its essence – it’s mostly wrong timing, pushy behavior and lack of preceding interest. Visits that come out of the blue and take precious time are clearly not as effective. That is why HCPs now prefer a 50% to 50% proportion of face-to-face rep visits to remote detailing sessions. The advantages of this eDetailing type are more or less obvious; what makes them especially effective in a virtual platform setting is, there is background. The rep tells about the things the physician wants to know about – because they requested a session (or were offered one) on that same platform. The Glory of eLearning Techniques To add a final touch to the virtual HCP engagement platform, think of something that makes it even more valuable to users. Yes, users – the doctors are not just potential customers here, they are supposed to join the platform for their own benefit. Ultimately, all the possibilities provided by the platform are, for them, focused on learning the new information. And the recent trend has been, eLearning outperforms the conventional ways on multiple scales. This is acknowledged: the share of eLearning industry in corporate training is now estimated at $107 billion out of $200 billion – eLearning is something that people genuinely enjoy as an experience; it takes less time, and information retention is higher. What makes eLearning so popular? There are several things that set it apart from the traditional methods, so we can consider emulating them: Activities, Not Just Information First and foremost, eLearning is based on interactive types of content. Doing quizzes, simulations, different tasks is a useful way to keep concentrated; besides, we humans are simply wired to memorize what we do better than what happens elsewhere (for example, in a lengthy research paper). Interactive exercise and testing is potentially the cherry-on-top that makes a platform unique and valuable. Gamification Who said HCPs don’t deserve fun, even when learning complicated materials? After all, gamified experiences serve to increase the willingness to access information – and are successful at this. When surveyed, 80% eLearners have claimed to wish for more game-oriented activities; the use of such tactics can make the platform more frequently used. Interactivity When eLearning was just starting to take over, much effort was thrown in to compensate for the physical absence of a lecturer. As the result, the interface used in distant learning tech is designed so that the user has to interact all the time. Instead of being distracted from the content, the user is distracted from side thoughts towards the content. Competitiveness Have you ever noticed that some online quizzes offer to compare your results to the average? This is done on purpose. People are, in fact, interested in being part of a community and being rated within it – this provides a sense of real achievement. Reward System Another feature that makes eLearning so engaging, a sense of reward can be provided in multiple ways. It can be a personalized invitation to a really interesting (web) meeting or event, access to some especially elaborate content, etc. The last two points depend on organization, and are best implemented when there already is a community, so it takes some time to figure them out. At the same time, the core eLearning features (at the top of the list) rely simply on the ability to produce interactive content. The key is to develop a set of tailored templates (click, switch, drag and drop, mark the boxes, etc.) that can be used for multiple activities. In this way, a quiz on coronal artery can become a quiz on cerebellar function without much coding done. The necessary amount of interactive content can be created quite fast using templates and a suitable tool for repurposing content – a job that can be done by those same agencies that make eDetails. A virtual HCP engagement platform is, so far, the most effective way to steer pharma communications with extra value for the audience. Good thing is, these platforms are something you can build gradually, extending upon a certain base of available content – until it becomes a frequented virtual haven for medical professionals. Personalize HCP Experiences with eWizard Powered by Viseven, eWizard is a content experience platform that allows a pharmaceutical company with any level of digital maturity to create and implement HCP digital engagement strategies of any purpose and scale. eWizard’s functionality includes a wide range of widgets and tools to: Streamline Content Production Use a rich collection of ready-made templates to create content for emails, eDetailers, and other marketing channels faster and at reduced cost. Accelerate MLR Approval Increase time-to-market and deliver high-quality content to your target audience faster by reducing the medical, legal, and regulatory (MLR) review process with the modular approach. Omnichannel Campaign Management Plan global and local marketing campaigns, create campaign roadmaps, estimate campaign expenditures, track time, and view the progress of marketing objectives in a single environment. Enhance Cooperation and Workflows Create user accounts, assign roles, and organize users into groups to optimize collaboration between multiple stakeholders within different teams, departments, and organizations. Generate High-Quality Videos with AI Convert existing presentations into videos or generate new videos from scratch using AI-powered avatars that speak over 40 languages and pre-built-templates. Edit and add text, images, GIFs, animation, music, and stickers. Render videos in one click and download them in 1080p or 4K. Need more information about the platform? Contact our specialist or request a demo of eWizard now.